Features Screener Stocks Charts
Sign In Sign Up

Strides Arcolab Financial Statements

NSE: STAR | BSE: 532531 | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 5 years of history.

View Plans

Strides Arcolab (STAR) reported revenue of ₹46.24B in FY2025 with net income of ₹35.98B. Total assets stood at ₹60.49B and free cash flow was ₹4.42B.

Strides Arcolab Income Statement

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025
Item Chart 2024 2025
Revenue 40.91B 46.24B
Cost of Rev. -16.41B -19.80B
Gross Profit 24.50B 26.44B
SGA -16.67B -17.83B
Op. Income 5.62B 6.69B
PBT -1.17B 4.87B
Net Income -943.14M 35.98B
Dil. Shares 90.88M 92.02M
Diluted EPS -7.77 390.50

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Strides Arcolab's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Strides Arcolab Balance Sheet

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025
Item Chart 2024 2025
Curr. assets 29.69B 30.99B
Non-curr. assets 28.71B 29.50B
Total assets 58.40B 60.49B
Curr. liabilities 28.79B 25.92B
Non-curr. liab. 8.89B 8.71B
Total liabilities 37.68B 34.62B
Total equity 20.72B 25.86B
Total liab. & eq. 58.40B 60.49B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Strides Arcolab's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Strides Arcolab Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2024 – FY 2025
Item Chart 2024 2025
Net Income -627.22M 36.75B
Operating CF 7.01B 6.84B
Capex -1.18B -2.42B
Investing CF -1.50B -896.89M
Dividend Paid -135.17M -229.90M
Financing CF -6.93B -6.43B
Cash (start) 3.04B 1.61B
Cash (end) 1.61B 1.13B
FCF 5.83B 4.42B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Strides Arcolab's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025

Related Stocks